Microbiome applications for pathology: challenges of low microbial biomass samples during diagnostic testing

33Citations
Citations of this article
69Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The human microbiome can play key roles in disease, and diagnostic testing will soon have the ability to examine these roles in the context of clinical applications. Currently, most diagnostic testing in pathology applications focuses on a small number of disease-causing microbes and dismisses the whole microbial community that causes or is modulated by disease. Microbiome modifications have already provided clinically relevant insights in gut and oral diseases, such as irritable bowel disease, but there are currently limitations when clinically examining microbiomes outside of these body sites. This is critical, as the majority of microbial samples used in pathology originate from body sites that contain low concentrations of microbial DNA, including skin, tissue, blood, and urine. These samples, also known as low microbial biomass samples, are difficult to examine without careful consideration and precautions to mitigate contamination and biases. Here, we present the limitations when analysing low microbial biomass samples using current protocols and techniques and highlight the advantages that microbiome testing can offer diagnostics in the future, if the proper precautions are implemented. Specifically, we discuss the sources of contamination and biases that may result in false assessments for these sample types. Finally, we provide recommendations to mitigate contamination and biases from low microbial biomass samples during diagnostic testing, which will be especially important to effectively diagnose and treat patients using microbiome analyses.

Cited by Powered by Scopus

New opportunities for endometrial health by modifying uterine microbial composition: Present or future?

126Citations
N/AReaders
Get full text

The intratumor mycobiome promotes lung cancer progression via myeloid-derived suppressor cells

70Citations
N/AReaders
Get full text

Optimisation of sample storage and DNA extraction for human gut microbiota studies​

44Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Selway, C. A., Eisenhofer, R., & Weyrich, L. S. (2020, April 1). Microbiome applications for pathology: challenges of low microbial biomass samples during diagnostic testing. Journal of Pathology: Clinical Research. Wiley-Blackwell Publishing Ltd. https://doi.org/10.1002/cjp2.151

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 24

67%

Researcher 10

28%

Professor / Associate Prof. 1

3%

Lecturer / Post doc 1

3%

Readers' Discipline

Tooltip

Biochemistry, Genetics and Molecular Bi... 20

61%

Agricultural and Biological Sciences 5

15%

Veterinary Science and Veterinary Medic... 4

12%

Immunology and Microbiology 4

12%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 130

Save time finding and organizing research with Mendeley

Sign up for free